SCOPUS 정보 검색 플랫폼

Volumn 116, Issue 1, 2002, Pages 229-235

A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma

(15) Lazzarino, Mario a Arcaini, L a Bernasconi, P a Alessandrino, E P a Gargantini, L b Cairoli, R b Orlandi, E a Astori, C a Brusamolino, E a Pagnucco, G a Colombo, A A a Calatroni, S a Iacona, I c Regazzi, M B c Morra, E b

a UNIVERSITY OF PAVIA (Italy)

b OSPEDALE NIGUARDA CA GRANDA (Italy)

c FONDAZIONE IRCCS POLICLINICO SAN MATTEO (Italy)

Author keywords

Autologous transplant; Follicular lymphoma; Immuno chemotherapy; Mantle cell lymphoma; Rituximab

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; ADVANCED CANCER; ARTICLE; AUTOGRAFT; AUTOTRANSPLANTATION; BLOOD; BONE MARROW; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; FOLLICULAR LYMPHOMA; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNOTHERAPY; IN VIVO STUDY; MALE; MANTLE CELL LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL MOBILIZATION; TOXICITY; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BONE MARROW PURGING; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FEMALE; GENE REARRANGEMENT; GENES, BCL-2; HALF-LIFE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA; LYMPHOMA, FOLLICULAR; LYMPHOMA, MANTLE-CELL; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREDNISONE; RECURRENCE; TRANSPLANTATION, AUTOLOGOUS; VINCRISTINE;

EID: 0036162331 PISSN: 00071048 EISSN: None Source Type: Journal
DOI: 10.1046/j.1365-2141.2002.03256.x Document Type: Article

Times cited : (56)

References (15)

1
- 17344374408
- High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: Long-term clinical and molecular follow-up
- (2000) Journal of Clinical Oncology , vol.18 , pp. 527-536
- Apostolidis, J.¹ Gupta, R.K.² Grenzelias, D.³ Johnson, P.W.⁴ Pappa, V.I.⁵ Summers, K.E.⁶ Salam, A.⁷ Adams, K.⁸ Norton, A.J.⁹ Amess, J.A.¹⁰ Matthews, J.¹¹ Bradburn, M.¹² Lister, T.A.¹³ Rohatiner, A.Z.¹⁴

2
- 0042449063
- Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas
- NCI Sponsored International Working Group
- (1999) Journal of Clinical Oncology , vol.17 , pp. 1244-1253
- Cheson, B.D.¹ Horning, S.J.² Coier, B.³ Shipp, M.A.⁴ Fisher, R.I.⁵ Connors, J.M.⁶ Lister, T.A.⁷ Vose, J.⁸ Grillo-Lopez, A.⁹ Hagenbeek, A.¹⁰ Cabanillas, F.¹¹ Klippensten, D.¹² Hiddemann, W.¹³ Castellino, R.¹⁴ Harris, N.L.¹⁵ Armitage, J.O.¹⁶ Carter, W.¹⁷ Hoppe, R.¹⁸ Canellos, G.P.¹⁹

3
- 0033139797
- Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma patients
- (1999) Haematologica , vol.84 , pp. 14-18
- Coiffier, B.¹

4
- 0344766075
- Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy
- (1999) Journal of Clinical Oncology , vol.17 , pp. 268-276
- Czuczman, M.S.¹ Grillo-Lopez, A.J.² White, C.A.³ Saleh, M.⁴ Gordon, L.⁵ LoBuglio, A.F.⁶ Jonas, C.⁷ Klippenstein, D.⁸ Dallaire, B.⁹ Varns, C.¹⁰

5
- 0033570991
- Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphomas
- (1999) Blood , vol.94 , pp. 3325-3333
- Freedman, A.S.¹ Neuberg, D.² Mauch, P.³ Soier, R.J.⁴ Anderson, K.C.⁵ Fisher, D.C.⁶ Schlossman, R.⁷ Alyea, E.P.⁸ Takvorian, T.⁹ Jallow, H.¹⁰ Kuhlman, C.¹¹ Ritz, J.¹² Nadler, L.M.¹³ Gribben, J.G.¹⁴

6
- 0026736662
- Bone marrow of non-Hodgkin's lymphoma patients with a bcl-2 translocation can be purged of polymerase chain reaction-detectable lymphoma cells using monoclonal antibodies and immunomagnetic bead depletion
- (1992) Blood , vol.80 , pp. 1083-1089
- Gribben, J.G.¹ Saporito, L.² Barber, M.³ Blake, K.W.⁴ Edwards, R.M.⁵ Grin, J.D.⁶ Freedman, A.S.⁷ Nadler, L.M.⁸

7
- 0027235630
- Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma
- (1993) Blood , vol.81 , pp. 3449-3457
- Gribben, J.G.¹ Neuberg, D.² Freedman, A.S.³ Gimmi, C.D.⁴ Pesek, K.W.⁵ Barber, M.⁶ Saporito, L.⁷ Woo, S.D.⁸ Coral, F.⁹ Spector, N.¹⁰

8
- 0035863908
- High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: Results of a phase II clinical trial
- (2001) Blood , vol.97 , pp. 404-409
- Horning, S.J.¹ Negrin, R.S.² Hoppe, R.T.³ Rosenberg, S.⁴ Chao, N.J.⁵ Long, G.D.⁶ Brown, B.W.⁷ Blume, K.G.⁸

9
- 0034090042
- Rituximab (IDEC-C2B8): Validation of a sensitive enzyme-linked immunoassay applied to a clinical pharmacokinetic study
- (2000) Therapeutic Drug Monitoring , vol.22 , pp. 295-301
- Iacona, I.¹ Lazzarino, M.² Avanzini, M.A.³ Rupolo, M.⁴ Arcaini, L.⁵ Astori, C.⁶ Lunghi, F.⁷ Orlandi, E.⁸ Morra, E.⁹ Zagonel, V.¹⁰ Regazzi, M.B.¹¹

10
- 0033065253
- Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphoma
- (1999) Annals of Oncology , vol.10 , pp. 59-64
- Lazzarino, M.¹ Orlandi, E.² Montillo, M.³ Tedeschi, A.⁴ Pagnucco, G.⁵ Astori, C.⁶ Corso, A.⁷ Brusamolino, E.⁸ Simoncini, L.⁹ Morra, E.¹⁰ Bernasconi, C.¹¹

11
- 0034254354
- Successful in vivo purging of CD34-containing peripheral blood harvest in mantle cell and indolent lymphoma: Evidence for a role of both chemotherapy and rituximab infusion
- (2000) Blood , vol.96 , pp. 864-869
- Magni, M.¹ DiNicola, M.² Devizzi, L.³ Matteucci, P.⁴ Lombardi, F.⁵ Gandola, L.⁶ Ravagnani, F.⁷ Giardini, R.⁸ Dastoli, G.⁹ Tarella, C.¹⁰ Pileri, A.¹¹ Bonadonna, G.¹² Gianni, A.M.¹³

12
- 0029991369
- Fludarabine, mitoxantrone, and dexamethasone: An effective new regimen for indolent lymphoma
- (1996) Journal of Clinical Oncology , vol.14 , pp. 1262-1268
- McLaughlin, P.¹ Hagemeister, F.B.² Romaguera, J.E.³ Sarris, A.H.⁴ Pate, O.⁵ Younes, A.⁶ Swan, F.⁷ Keating, M.⁸ Cabanillas, F.⁹

13
- 0345337254
- Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program
- (1998) Journal of Clinical Oncology , vol.16 , pp. 2825-2833
- McLaughlin, P.¹ Grillo-Lopez, A.J.² Link, B.K.³ Levy, R.⁴ Czuczman, M.S.⁵ Williams, M.E.⁶ Heyman, M.R.⁷ Bence-Bruckler, I.⁸ White, C.A.⁹ Cabanillas, F.¹⁰ Jain, V.¹¹ Ho, A.D.¹² Lister, J.¹³ Wey, K.¹⁴ Shen, D.¹⁵ Dallaire, B.K.¹⁶

14
- 0028270019
- Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas
- (1994) Blood , vol.83 , pp. 1871-1875
- Rimokh, R.¹ Berger, F.² Delsol, G.³ Digonnet, I.⁴ Rouault, J.P.⁵ Tigaud, J.D.⁶ Gadoux, M.⁷ Coier, B.⁸ Bryon, P.A.⁹ Magaud, J.P.¹⁰

15
- 0033861062
- In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and Rituximab for autografting in patients with non-Hodgkin's lymphoma
- (2000) British Journal of Haematology , vol.109 , pp. 729-735
- Voso, M.T.¹ Pantel, G.² Weis, M.³ Schmidt, P.⁴ Martin, S.⁵ Moos, M.⁶ Ho, A.D.⁷ Haas, R.⁸ Hohaus, S.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.